AIQUY:OTC-L'Air Liquide S.A (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 33.37

Change

+0.21 (+0.63)%

Market Cap

USD 78.42B

Volume

0.29M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


L'Air Liquide S.A (AIQUY) Stock Analysis:
Based on the L'Air Liquide S.A stock forecasts from 0 analysts, the average analyst target price for L'Air Liquide S.A is not available over the next 12 months. L'Air Liquide S.A’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of L'Air Liquide S.A is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, L'Air Liquide S.A’s stock price was USD 33.37. L'Air Liquide S.A’s stock price has changed by +1.12% over the past week, -4.52% over the past month and -1.48% over the last year.

No recent analyst target price found for L'Air Liquide S.A
No recent average analyst rating found for L'Air Liquide S.A

About

L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. The company's Gas & Services segment offers oxygen, nitrogen, argon, hydrogen, and carbon monoxide to the me ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-16 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SKFOF Sika AG

-0.65 (-0.24%)

USD39.10B 40.27 22.64
SXYAY Sika AG

-0.32 (-1.20%)

USD38.07B 39.56 22.64
GVDBF Givaudan SA

N/A

USD33.66B 41.14 25.58
GVDNY Givaudan SA

+0.36 (+0.50%)

USD33.09B 40.08 25.58
KDSKF Koninklijke DSM N.V

-1.20 (-0.81%)

USD25.51B 14.53 15.86
RDSMY Koninklijke DSM N.V

-0.24 (-0.65%)

USD25.38B 14.44 15.86
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.28B 38.79 27.27
NPCPF Nippon Paint Holdings Co. Ltd

N/A

USD18.56B 34.81 0.16
NVZMF Novozymes A/S

N/A

USD17.36B 39.31 4.16
SCVUF The Siam Cement Public Company..

N/A

USD16.69B 12.18 0.19

ETFs Containing AIQUY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.30% 76% C 65% D
Dividend Return 1.86% 50% F 45% F
Total Return -2.44% 71% C- 64% D
Trailing 12 Months  
Capital Gain -1.72% 82% B- 72% C-
Dividend Return 1.91% 40% F 24% F
Total Return 0.19% 76% C 70% C-
Trailing 5 Years  
Capital Gain 51.17% 75% C 74% C
Dividend Return 14.30% 81% B- 49% F
Total Return 65.47% 79% C+ 74% C
Average Annual (5 Year Horizon)  
Capital Gain 9.53% 45% F 47% F
Dividend Return 2.35% 60% D- 52% F
Total Return 11.87% 53% F 47% F
Risk Return Profile  
Volatility (Standard Deviation) 10.30% 99% A+ 94% A
Risk Adjusted Return 115.29% 95% A 99% A+
Market Capitalization 78.42B 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 29.05 31% F 22% F
Price/Book Ratio 3.46 27% F 28% F
Price / Cash Flow Ratio 14.08 30% F 12% F
EV/EBITDA 14.94 32% F 20% F
Management Effectiveness  
Return on Equity 13.13% 61% D- 73% C
Return on Invested Capital 10.00% 59% F 69% D+
Return on Assets 5.53% 70% C- 82% B-
Debt to Equity Ratio 48.61% 32% F 34% F
Technical Ratios  
Dividend Yield 2.02% 40% F 24% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.56 76% C 64% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector